QIAGEN

About QIAGEN

QIAGEN is a leading global provider of sample and assay technologies, dedicated to transforming biological samples into valuable insights. Founded in 1986, the company has established itself as a pioneer in the field of molecular diagnostics and life sciences. With a strong commitment to innovation, QIAGEN develops products that enable researchers and healthcare professionals to unlock the potential of genetic information.

The company’s core activities include the development of sample preparation solutions, which are essential for isolating and purifying nucleic acids from various biological materials. QIAGEN’s extensive portfolio also features a wide range of assays for applications in clinical research, drug development, and personalized medicine.

With a presence in over 25 countries, QIAGEN serves customers in academia, pharmaceutical, and biotechnology sectors. The company is driven by its vision to make improvements in life possible by providing tools that enhance the understanding of diseases and facilitate the development of new therapies.

QIAGEN is committed to sustainability and corporate responsibility, ensuring that its operations have a positive impact on society and the environment. The company invests significantly in research and development to stay at the forefront of technological advancements in genomics and molecular biology.

In addition to its innovative products, QIAGEN offers comprehensive support services, including training and technical assistance, to help customers achieve their research goals. The company’s dedication to quality and reliability has earned it a reputation as a trusted partner in the scientific community.

As QIAGEN continues to expand its capabilities and product offerings, it remains focused on its mission to empower researchers and clinicians with the tools they need to make groundbreaking discoveries and improve patient outcomes.